Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 31
Filter
1.
Article in English | MEDLINE | ID: mdl-38833092

ABSTRACT

BACKGROUND: Guided by Andersen's Behavioral Model of Health Services Use (BMHSU), this study aimed to identify determinants of post-migration healthcare use among a sample of Mexican immigrants in a US-Mexico border region in Southern Arizona, while considering pre-migration health and healthcare experiences. METHODS: A non-probabilistic convenience sample of 300 adult Mexican immigrants completed a telephone survey to assess healthcare practices. Multivariable logistic regressions were fitted to determine adjusted relationships between frequency of care and predisposing, enabling, need, and contextual factors as well as personal health practices. RESULTS: Overall, participants had a 79% probability of receiving healthcare "at least once a year" after migrating to Southern Arizona. Receiving post-migration healthcare was associated with predisposing, enabling, need, contextual factors, and personal health practices (p < 0.05). DISCUSSION: Consistent with BMHSU, our findings suggest that frequency of healthcare is not only a function of having post-migration health insurance but is also shaped by a complex array of other factors. The results of this study shed light onto potential areas to be leveraged by multifactorial sociocultural interventions to increase Mexican immigrants' frequency of healthcare services use.

2.
Soc Sci Med ; 351: 116982, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38788427

ABSTRACT

Mexicans in the United States have been reported to maintain practices of Mexican traditional medicine at comparably higher rates than most other populations, including other Latino sub-groups. In this cross-sectional study, we examined the pre- and post-migration traditional medicine practices of first-generation immigrants from Mexico living in southern Arizona. Our objective was to assess how migration affected Mexican immigrants' ethnomedical practices and to better understand the mechanisms and motivating factors for the post-migration maintenance of practice. We designed a survey instrument based off prior qualitative data on traditional medicine practices and translated it into Spanish. The survey measured the rates and frequency of six domains of lay healing practices: herbal medicine, healing foods, self-medication with over-the-counter medicine, and three types of specialty healers (curandero/a, and sobador/a, or partero/a), and asked questions about knowledge sources, reasons for maintaining practice post-migration, and to what extent participants believed the remedies were effective. The research team fielded the telephone-based survey from April 2022 to February 2023 to 300 first-generation adult Mexican immigrants residing in southern Arizona. A series of proportions tests were conducted to examine differences in reliance on lay healing pre- and post-migration as well as to assess differences between women's and men's lay practices. The data indicate a general, but moderated decline in lay medical practices post-migration, with the usage of expert healers declining at much higher rates than the three self-care domains. Women tend to use herbal medicine and healing foods at higher rates than men post-migration. This cross-sectional quantitative study confirms prior research indicating that traditional medicine practices are heavily relied upon by Mexican origin people both pre- and post-migration. These findings suggest that public health messaging and medical providers should better address and harness Mexican immigrants' lay medical practices in order to optimize health in this population.


Subject(s)
Medicine, Traditional , Humans , Arizona , Male , Female , Cross-Sectional Studies , Medicine, Traditional/statistics & numerical data , Medicine, Traditional/methods , Adult , Middle Aged , Emigrants and Immigrants/statistics & numerical data , Emigrants and Immigrants/psychology , Mexican Americans/statistics & numerical data , Mexican Americans/psychology , Mexico/ethnology , Health Knowledge, Attitudes, Practice , Surveys and Questionnaires , Aged , North American People
3.
Fam Community Health ; 47(2): 151-166, 2024.
Article in English | MEDLINE | ID: mdl-38372332

ABSTRACT

This study sought to quantify the contributions of state-level factors including income inequality, state's legislature political control, and Medicaid expansion in new and established Latinx destination states on Latinx individuals' treated hypertension. Mixed-effects logistic regression analyses were conducted to analyze 2017 Behavioral Risk Factor Surveillance System data from 7524 Latinx adults nested within 39 states. Overall, 70% reported being pharmacologically treated for hypertension, and 66% resided in established destination states. Compared with Latinx people in established destination states, Latinx people in new destinations had lower odds of having treated hypertension (odds ratio [OR] = 0.72, 95% CI = 0.54-0.95). Within established Latinx destinations, the odds of treated hypertension were lower in states where legislatures expanded Medicaid than in states that did not expand Medicaid (OR = 0.84, 95% CI = 0.79-0.89). However, after controlling for the effects of individual-level factors, this association was no longer statistically significant. In new Latinx destination states, Medicaid expansion, legislatures' political control, and income inequality were not associated with treated hypertension. The study results highlight the importance of considering both individual- and state-level factors, as the interplay of such factors could hinder the successful implementation of cardiovascular risk reduction interventions.


Subject(s)
Hypertension , Medicaid , Adult , United States , Humans , Multilevel Analysis , Hypertension/drug therapy , Hypertension/epidemiology , Hispanic or Latino
4.
Prev Med Rep ; 32: 102147, 2023 Apr.
Article in English | MEDLINE | ID: mdl-36865397

ABSTRACT

Although available evidence indicates that Mexican-origin (MO) adults experience unique stressful life events, little is known about how stress may influence risk for developing non-alcoholic fatty liver disease (NAFLD) for this high-risk group. This study investigated the association between perceived stress and NAFLD and explored how this relationship varied by acculturation levels. In a cross-sectional study, a total of 307 MO adults from a community-based sample in the U.S-Mexico Southern Arizona border region completed self-reported measures of perceived stress and acculturation. NAFLD was identified as having a continuous attenuation parameter (CAP) score of ≥ 288 dB/m determined by FibroScan®. Logistic regression models were fitted to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for NAFLD. The prevalence of NAFLD was 50 % (n = 155). Overall, perceived stress was high (Mean = 15.9) for the total sample. There were no differences by NAFLD status (No NAFLD: Mean = 16.6; NAFLD: Mean = 15.3; p = 0.11). Neither perceived stress nor acculturation were associated with NAFLD status. However, the association between perceived stress and NAFLD was moderated by acculturation levels. Specifically with each point increase in perceived stress, the odds of having NAFLD were 5.5 % higher for MO adults with an Anglo orientation and 1.2 % higher for bicultural MO adults. In contrast, the odds of NAFLD for MO adults with a Mexican cultural orientation were 9.3 % lower with each point increase in perceived stress. In conclusion, results highlight the need for additional efforts to fully understand the pathways through which stress and acculturation may influence the prevalence of NAFLD in MO adults.

5.
J Immigr Minor Health ; 25(1): 50-61, 2023 Feb.
Article in English | MEDLINE | ID: mdl-35794448

ABSTRACT

Little is known about the influence of social and environmental contexts on Latino hypertension-related disparities. This study examined the influence of social determinants of cardiovascular health on medically treated hypertension, contrasting established vs. new Latino destination states. Logistic regression models were fitted to analyze 2017 Behavioral Risk Factors Surveillance Survey data from 8,999 Latinos. Overall, 70.4% indicated having treated hypertension. History of diabetes (OR = 2.60) and access to healthcare (OR = 2.38) were associated with treated hypertension, regardless of destination state. In established destinations, Latinos who graduated high school (OR = 1.19) or attended college (OR = 1.32) had higher odds of treated hypertension; whereas those who completed college were less likely to have treated hypertension (OR = 0.80). In contrast, in both new and non-destination states, the odds of treated hypertension were consistently lower across levels of educational attainment. Results highlight the need for cardiovascular-risk reduction interventions to incorporate the social and environmental context in the development process.


Subject(s)
Diabetes Mellitus , Hypertension , Humans , United States/epidemiology , Social Determinants of Health , Hypertension/epidemiology , Hispanic or Latino , Risk Factors , Diabetes Mellitus/therapy , Diabetes Mellitus/epidemiology
6.
Rev. Paul. Pediatr. (Ed. Port., Online) ; 41: e2021267, 2023. tab, graf
Article in English | LILACS-Express | LILACS | ID: biblio-1406941

ABSTRACT

Abstract Objective: This study aimed to describe the clinical characteristics and the different phenotypes of children with multisystem inflammatory syndrome in children (MIS-C) temporally related to COVID-19 and to evaluate the risk conditions that favored a greater severity of the disease during a 12-month period at a pediatric reference hospital in Colombia. Methods: A 12-month retrospective observational study of children under the age of 18 years who met criteria for MIS-C. Results: A total of 28 children presented MIS-C criteria. The median age was 7 years. Other than fever (100%) (onset 4 days prior to admission), the most frequent clinical features were gastrointestinal (86%) and mucocutaneous (61%). Notably, 14 (50%) children had Kawasaki-like symptoms. The most frequent echocardiographic abnormalities were pericardial effusion (64%), valvular involvement (68%), ventricular dysfunction (39%), and coronary artery abnormalities (29%). In addition, 75% had lymphopenia. All had at least one abnormal coagulation test. Most received intravenous immunoglobulin (89%), glucocorticoids (82%), vasopressors (54%), and antibiotics (64%). Notably, 61% had a more severe form of the disease and were admitted to an intensive care unit (median 4 days, mean 6 days); the severity predictors were patients with the inflammatory/MIS-C phenotype (OR 26.5; 95%CI 1.40-503.7; p=0.029) and rash (OR 14.7; 95%CI 1.2-178.7; p=0.034). Two patients had macrophage activation syndrome. Conclusions: Coronary artery abnormalities, ventricular dysfunction, and intensive care unit admission were frequent, which needs to highlight the importance of early clinical suspicion.


Resumo Objetivo: Descrever as características clínicas e os diferentes fenótipos de crianças com síndrome inflamatória multissistêmica na criança temporalmente relacionada com a COVID-19 (do inglês multisystem inflammatory syndrome in children — MIS-C) e avaliar as condições de risco que favorecem a maior gravidade da doença durante um período de 12 meses em um hospital pediátrico de referência na Colômbia. Métodos: Estudo retrospectivo de 12 meses de observação de crianças menores de 18 anos que cumprem os critérios para o MIS-C. Resultados: Vinte e oito crianças foram apresentadas com os critérios do MIS-C. A idade média era de sete anos, e 54% eram do sexo masculino. Para além da febre (100%) (com início quatro dias antes da admissão), as características clínicas mais frequentes eram gastrointestinais (86%) e mucocutâneas (61%). Quatorze crianças (50%) apresentavam sintomas semelhantes aos de Kawasaki. As anomalias ecocardiográficas mais frequentes foram derrame pericárdico (64%), envolvimento valvar (68%), disfunção ventricular (39%) e anomalias coronárias (29%). Tinham linfopenia 75% das crianças. Todas tinham algum teste de coagulação anormal. A maioria recebeu imunoglobulina intravenosa (89%), glucocorticoides (82%), vasopressores (54%) e antibióticos (64%). Tiveram envolvimento mais grave 61% dos pacientes, que precisaram ser internados em unidade de terapia intensiva (mediana de quatro dias, média de seis dias); os preditores de gravidade foram pacientes com fenótipo inflamatório/ MIS-C (odds ratio — OR 26,5; intervalo de confiança — IC95% 1,4-503,7; p=0,029) e erupção cutânea (OR 14,7; IC95% 1,2-178,7; p=0,034). Dois pacientes (7%) apresentavam síndrome de ativação macrofágica. Conclusões: Alteração da artéria coronária, disfunção ventricular e internação na unidade de terapia intensiva foram frequentes, o que nos alerta sobre a importância da suspeita clínica precoce.

7.
Rev Paul Pediatr ; 41: e2021267, 2022.
Article in English | MEDLINE | ID: mdl-36383790

ABSTRACT

OBJECTIVE: This study aimed to describe the clinical characteristics and the different phenotypes of children with multisystem inflammatory syndrome in children (MIS-C) temporally related to COVID-19 and to evaluate the risk conditions that favored a greater severity of the disease during a 12-month period at a pediatric reference hospital in Colombia. METHODS: A 12-month retrospective observational study of children under the age of 18 years who met criteria for MIS-C. RESULTS: A total of 28 children presented MIS-C criteria. The median age was 7 years. Other than fever (100%) (onset 4 days prior to admission), the most frequent clinical features were gastrointestinal (86%) and mucocutaneous (61%). Notably, 14 (50%) children had Kawasaki-like symptoms. The most frequent echocardiographic abnormalities were pericardial effusion (64%), valvular involvement (68%), ventricular dysfunction (39%), and coronary artery abnormalities (29%). In addition, 75% had lymphopenia. All had at least one abnormal coagulation test. Most received intravenous immunoglobulin (89%), glucocorticoids (82%), vasopressors (54%), and antibiotics (64%). Notably, 61% had a more severe form of the disease and were admitted to an intensive care unit (median 4 days, mean 6 days); the severity predictors were patients with the inflammatory/MIS-C phenotype (OR 26.5; 95%CI 1.40-503.7; p=0.029) and rash (OR 14.7; 95%CI 1.2-178.7; p=0.034). Two patients had macrophage activation syndrome. CONCLUSIONS: Coronary artery abnormalities, ventricular dysfunction, and intensive care unit admission were frequent, which needs to highlight the importance of early clinical suspicion.


Subject(s)
COVID-19 , Ventricular Dysfunction , Child , Humans , COVID-19/complications , SARS-CoV-2 , Colombia/epidemiology , Hospitals, Pediatric
8.
Front Public Health ; 10: 1090101, 2022.
Article in English | MEDLINE | ID: mdl-36684893

ABSTRACT

Introduction: The burden of non-alcoholic fatty liver disease (NAFLD) continues to disproportionately impact under-resourced communities in the U.S., particularly Mexican-origin populations. Genetic polymorphisms such as the rs738409 C/G variant in patatin-like phospholipase domain-containing 3 (PNPLA3) have been associated with higher prevalence of and progression along the NAFLD spectrum. This qualitative study conducted in the U.S. Southwest aimed to assess Mexican-origin men's experience receiving genetic testing for PNPLA3 risk carrier status. Methods: Semi-structured interviews were conducted with 17 Mexican-origin men whose NAFLD status and genetic predisposition were determined as part of a previous cross-sectional study. The interview guide included questions exploring participants' insights on how genetic risk status was delivered, how the information influenced their motivation for lifestyle modification to reduce NAFLD risk, and any knowledge sharing that occurred with family members after learning of their PNPLA3 risk status. Interviews were conducted and audio recorded in English (n = 6) and Spanish (n = 11) and uploaded into NVivo software for data analysis and interpretation. Guided by the Health Belief Model, a thematic analysis approach was used to identify primary themes. Results: Results highlighted men's preference for receiving this type of genetic risk information through a letter sent to their homes. General comprehension of PNPLA3 risk status was deemed high and most men stated sharing their genetic predisposition to NAFLD with their immediate family members. Participants also indicated that family and awareness of this genetic risk acted as primary motivators for implementing behavior changes (e.g., diet, physical activity) toward the prevention of more severe liver conditions. Discussion: Findings from this qualitative study suggest the feasibility of communicating genetic risk for NAFLD among Mexican-origin men. Future strategies for the dissemination of genetic risk results among Mexican-origin individuals should consider familial and cultural appropriate strategies.


Subject(s)
Acyltransferases , Genetic Predisposition to Disease , Non-alcoholic Fatty Liver Disease , Phospholipases A2, Calcium-Independent , Humans , Male , Non-alcoholic Fatty Liver Disease/epidemiology , Non-alcoholic Fatty Liver Disease/genetics , Polymorphism, Single Nucleotide , Risk Factors , Acyltransferases/genetics , Phospholipases A2, Calcium-Independent/genetics
9.
Elife ; 102021 12 09.
Article in English | MEDLINE | ID: mdl-34882091

ABSTRACT

In eukaryotic cells, intracellular components are organized by the microtubule motors cytoplasmic dynein-1 (dynein) and kinesins, which are linked to cargos via adaptor proteins. While ~40 kinesins transport cargo toward the plus end of microtubules, a single dynein moves cargo in the opposite direction. How dynein transports a wide variety of cargos remains an open question. The FTS-Hook-FHIP ('FHF') cargo adaptor complex links dynein to cargo in humans and fungi. As human cells have three Hooks and four FHIP proteins, we hypothesized that the combinatorial assembly of different Hook and FHIP proteins could underlie dynein cargo diversity. Using proteomic approaches, we determine the protein 'interactome' of each FHIP protein. Live-cell imaging and biochemical approaches show that different FHF complexes associate with distinct motile cargos. These complexes also move with dynein and its cofactor dynactin in single-molecule in vitro reconstitution assays. Complexes composed of FTS, FHIP1B, and Hook1/Hook3 colocalize with Rab5-tagged early endosomes via a direct interaction between FHIP1B and GTP-bound Rab5. In contrast, complexes composed of FTS, FHIP2A, and Hook2 colocalize with Rab1A-tagged ER-to-Golgi cargos and FHIP2A is involved in the motility of Rab1A tubules. Our findings suggest that combinatorial assembly of different FTS-Hook-FHIP complexes is one mechanism dynein uses to achieve cargo specificity.


Subject(s)
Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Cytoplasmic Dyneins/metabolism , Endosomes/genetics , Endosomes/metabolism , Microtubule-Associated Proteins/genetics , Microtubule-Associated Proteins/metabolism , Cells, Cultured , Cytoplasmic Dyneins/genetics , Humans , Protein Transport/genetics , Protein Transport/physiology
10.
Mol Biol Cell ; 32(6): 492-503, 2021 03 15.
Article in English | MEDLINE | ID: mdl-33476181

ABSTRACT

In canonical microtubule-based transport, adaptor proteins link cargoes to dynein and kinesin motors. Recently, an alternative mode of transport known as "hitchhiking" was discovered, where cargoes achieve motility by hitching a ride on already-motile cargoes, rather than attaching to a motor protein. Hitchhiking has been best studied in two filamentous fungi, Aspergillus nidulans and Ustilago maydis. In U. maydis, ribonucleoprotein complexes, peroxisomes, lipid droplets (LDs), and endoplasmic reticulum hitchhike on early endosomes (EEs). In A. nidulans, peroxisomes hitchhike using a putative molecular linker, peroxisome distribution mutant A (PxdA), which associates with EEs. However, whether other organelles use PxdA to hitchhike on EEs is unclear, as are the molecular mechanisms that regulate hitchhiking. Here we find that the proper distribution of LDs, mitochondria, and preautophagosomes do not require PxdA, suggesting that PxdA is a peroxisome-specific molecular linker. We identify two new pxdA alleles, including a point mutation (R2044P) that disrupts PxdA's ability to associate with EEs and reduces peroxisome movement. We also identify a novel regulator of peroxisome hitchhiking, the phosphatase DipA. DipA colocalizes with EEs and its association with EEs relies on PxdA. Together, our data suggest that PxdA and the DipA phosphatase are specific regulators of peroxisome hitchhiking on EEs.


Subject(s)
Fungal Proteins/metabolism , Peroxisomes/metabolism , Phosphoric Monoester Hydrolases/metabolism , Protein Transport/physiology , Aspergillus nidulans/metabolism , Basidiomycota/metabolism , Biological Transport , Dyneins/metabolism , Endoplasmic Reticulum/metabolism , Endosomes/metabolism , Kinesins/metabolism , Metabolic Networks and Pathways , Microtubules/metabolism , Mitochondria/metabolism , Peroxisomes/physiology , Protein Transport/genetics , Transport Vesicles/metabolism
11.
Am J Community Psychol ; 67(1-2): 195-204, 2021 03.
Article in English | MEDLINE | ID: mdl-33040375

ABSTRACT

The Health Equity Advancement Lab (HEAL) at the University of Iowa College of Public Health began in 2012 to support students, researchers, and community members interested in tackling persistent health inequities through a community-based participatory research (CBPR) approach. Using concepts from critical consciousness theory, we developed an approach to building students', faculty members', and community partners' capacity to engage in CBPR to promote health equity that involved immersion in developing CBPR projects. Our paper describes the evolution of HEAL as a facilitating structure that provides a support network and engages diverse stakeholders in critical reflection as they participate in research to advance health equity, and resulting political efficacy and social action. We describe one HEAL-affiliated research project that employs a CBPR approach and has a strong focus on providing transformative learning experiences for students, faculty, and community members. We highlight challenges, successes, and lessons learned in the application of critical consciousness as a framework that engages diverse academic and community partners seeking to promote health equity. We argue that critical consciousness is a relevant theoretical framework to promote transformative learning among students, faculty, and community partners to promote health equity research in diverse communities.


Subject(s)
Health Equity , Capacity Building , Community-Based Participatory Research , Health Promotion , Humans , Leadership , Social Justice
12.
Reumatol. clín. (Barc.) ; 16(6): 437-446, nov.-dic. 2020. tab, graf
Article in Spanish | IBECS | ID: ibc-194661

ABSTRACT

OBJETIVO: Generar las recomendaciones para la atención de pacientes con enfermedades reumáticas que reciben terapias inmunomoduladoras e inmunosupresoras (fármacos convencionales, biológicos y moléculas pequeñas) durante la pandemia por COVID-19. MATERIALES Y MÉTODOS: Las recomendaciones se realizaron utilizando el método Delphi como herramienta de acuerdo. Se conformó un panel de expertos con trayectoria académica y experiencia en investigación en reumatología. Se realizó la búsqueda de la literatura y se generó el cuestionario del ejercicio Delphi conformado por 42 preguntas. El grado de acuerdo se logró con el 80% de aprobación de los participantes. RESULTADOS: Se conformó un grupo de 11 reumatólogos de 7 ciudades del país. La tasa de respuesta fue del 100% para las 3 rondas de consulta. En la primera ronda se logró acuerdo en 35 preguntas, en la segunda ronda 37 y en la tercera ronda se logró el acuerdo de las 42 preguntas. CONCLUSIÓN: La recomendación para la mayoría de los tratamientos inmunomoduladores utilizados en reumatología es continuar con las terapias en pacientes que no tengan la infección y suspenderlas en aquellos con diagnóstico de SARS-CoV-2/COVID-19


OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. RESULTS: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. CONCLUSION: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19


Subject(s)
Humans , Rheumatic Diseases/drug therapy , Immunologic Factors/administration & dosage , Antirheumatic Agents/administration & dosage , Coronavirus Infections/drug therapy , Rheumatic Diseases/complications , Practice Patterns, Physicians' , Withholding Treatment/trends , Coronavirus Infections/epidemiology , Pandemics/statistics & numerical data
13.
Rev. colomb. reumatol ; 27(3): 230-241, jul.-set. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1251664

ABSTRACT

RESUMEN Objetivo: Generar las recomendaciones para la atención de pacientes con enfermedades reumáticas que reciben terapias inmunomoduladoras e inmunosupresoras (fármacos convencionales, biológicos y moléculas pequeñas) durante la pandemia por COVID-19. Materiales y métodos: Las recomendaciones se realizaron utilizando el método Delphi como herramienta de acuerdo. Se conformó un panel de expertos con trayectoria académica y experiencia en investigación en reumatología. Se realizó la búsqueda de la literatura y se generó el cuestionario del ejercicio Delphi conformado por 42 preguntas. El grado de acuerdo se logró con el 80% de aprobación de los participantes. Resultados: Se conformó un grupo de 11 reumatólogos de 7 ciudades del país. La tasa de respuesta fue del 100% para las 3 rondas de consulta. En la primera ronda se logró acuerdo en 35 preguntas, en la segunda ronda 37 y en la tercera ronda se logró el acuerdo de las 42 preguntas. Conclusión: La recomendación para la mayoría de los tratamientos inmunomoduladores utilizados en reumatología es continuar con las terapias en pacientes que no tengan la infección y suspenderlas en aquellos con diagnóstico de SARS-CoV-2/COVID-19.


ABSTRACT Objective: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. Materials and methods: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. Results: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. Conclusion: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19.


Subject(s)
Humans , Patients , Rheumatic Diseases , COVID-19 , Therapeutics , Delphi Technique , Adult
14.
Reumatol Clin (Engl Ed) ; 16(6): 437-446, 2020.
Article in English, Spanish | MEDLINE | ID: mdl-32800760

ABSTRACT

OBJECTIVE: To produce recommendations for patients with rheumatological diseases receiving immunomodulatory and immunosuppressive therapies (conventional drugs, biologicals, and small molecules) during the COVID-19 pandemic. MATERIALS AND METHODS: The recommendations were determined using the Delphi method as an agreement tool. A panel of experts was formed, with academic backgrounds and research experience in rheumatology. A literature search was conducted and 42 questions were generated. The level of agreement was made with 80% of approval by the participants. RESULTS: A group of eleven rheumatologists from 7 cities in the country participated. The response rate was 100% for the three consultation rounds. In the first round, agreement was reached on 35 questions, on 37 in the second round, and on 42 questions in the third round. CONCLUSION: The recommendation for the majority of the pharmacological treatments used in rheumatology is to continue with immunomodulatory or immunosuppressive therapies in patients who do not have the infection, and to suspend it in patients with a diagnosis of SARS-CoV-2/COVID-19.


Subject(s)
Antirheumatic Agents/therapeutic use , Betacoronavirus , Coronavirus Infections/complications , Pandemics , Pneumonia, Viral/complications , Rheumatic Diseases/complications , Adult , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Antibodies, Monoclonal/adverse effects , Antibodies, Monoclonal/therapeutic use , Antimalarials/adverse effects , Antimalarials/therapeutic use , Antirheumatic Agents/adverse effects , Biological Products/adverse effects , Biological Products/therapeutic use , COVID-19 , Clinical Trials as Topic , Colombia , Coronavirus Infections/drug therapy , Delphi Technique , Drug Interactions , Drug Repositioning , Glucocorticoids/adverse effects , Glucocorticoids/therapeutic use , Humans , Immunoglobulins, Intravenous/therapeutic use , Immunologic Factors/adverse effects , Immunologic Factors/therapeutic use , Immunosuppressive Agents/adverse effects , Immunosuppressive Agents/therapeutic use , Multicenter Studies as Topic , Pneumonia, Viral/drug therapy , Rheumatic Diseases/drug therapy , SARS-CoV-2 , COVID-19 Drug Treatment
15.
Med. paliat ; 27(1): 58-62, ene.-mar. 2020. tab
Article in Spanish | IBECS | ID: ibc-194825

ABSTRACT

Las convulsiones epilépticas ocurren con frecuencia en pacientes con tumores cerebrales primarios o secundarios en unidades de cuidados paliativos. Con la progresión de la enfermedad y la proximidad del desenlace, algunos pacientes son incapaces de ingerir los fármacos por vía oral por lo que la administración de fármacos por otras vías es necesaria. El levetiracetam es un fármaco antiepiléptico efectivo con un bajo potencial de interacciones farmacológicas además de ser bien tolerado, lo que lo hace un fármaco idóneo en crisis epilépticas en pacientes paliativos. La formulación parenteral está autorizada solo para uso intermitente por vía intravenosa. En los últimos años, se han publicado casos clínicos y un estudio retrospectivo sobre el uso del fármaco por vía subcutánea (VSC), tanto con dosis intermitentes como en perfusión continua subcutánea (PCSC), con buenos resultados. Presentamos nuestra experiencia en el uso de levetiracetam en PCSC en 6 pacientes en nuestra Unidad de Cuidados Paliativos. Protocolo de indicación y metodología de administración. Se recogen características clínicas y datos básicos, rotación de la vía, accesos VSC y cambios, reacciones locorregionales, complicaciones clínicas o toxicidad relacionadas con el fármaco. Valoración de la efectividad de la terapia. En todos nuestros casos no hubo problemas de tolerancia local ni sistémica con buen control clínico salvo un caso que precisó asociar midazolam para controlar un estatus epiléptico. Nuestra experiencia y los trabajos publicados hasta ahora, sugieren que el tratamiento con levetiracetam en PCSC puede tener un papel importante en el manejo de las convulsiones epilépticas al final de la vida. Se necesitan más estudios para confirmar las experiencias clínicas que vamos adquiriendo y evidenciar científicamente la indicación de levetiracetam por VSC y poder dejar de hacer un uso "off-label". El levetiracetam subcutáneo puede ofrecer la posibilidad de prevenir y controlar las convulsiones epilépticas en pacientes oncológicos que requieran cuidados paliativos


Epileptic seizures occur frequently in patients with primary or secondary brain tumors in palliative care units. With the progression of the disease and the proximity of death, some patients are unable to take the drugs orally, and in this situations the administration of drugs by other routes is necessary. Levetiracetam is an effective antiepileptic drug with a low potential for interactions that is well tolerated, which makes it an ideal drug for the treatment of epileptic seizures in palliative care patients. The parenteral formulation is only authorized for intermittent administration through the intravenous route. In recent years some clinical cases and a retrospective study have been reported about the use of this drug in continuous and intermittent subcutaneous infusion with good results. We report our experience in the use of levetiracetam as subcutaneous infusion in 6 patients in our Palliative Care Unit, including the protocol for indication and administration method. We collected the clinical characteristics and basic data, as well as the changes, local reactions, clinical complications, and toxicities associated with this drug. We assessed therapy effectiveness. In all our cases we had no local or systemic tolerance issues, and achieved a good clinical control except for one case that required associating midazolam to control an epileptic status event. Our experience and the works published so far suggest that treatment with levetiracetam in subcutaneous infusion may have an important role in the management of epileptic seizures at the end of life. Nevertheless, further studies are needed to confirm our clinical experience in order to scientifically establish the indication of levetiracetam by the subcutaneous route, and discontinue the "off-label" use of this drug. Subcutaneous levetiracetam may offer an opportunity to prevent and control epileptic seizures in cancer patients requiring palliative care


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Levetiracetam/administration & dosage , Hospice Care , Seizures/drug therapy , Disease Progression , Epilepsy/drug therapy , Seizures/complications , Retrospective Studies , Midazolam/administration & dosage , Neoplasms/drug therapy , Epilepsy/prevention & control
16.
Rev. colomb. reumatol ; 25(4): 301-306, oct.-dic. 2018. graf
Article in Spanish | LILACS | ID: biblio-990963

ABSTRACT

RESUMEN La vasculitis primaria del sistema nervioso central es una enfermedad infrecuente que puede afectar a adultos y población pediátrica. Puede comprometer los vasos sanguíneos cerebrales tanto de mediano o gran calibre como los de pequeño calibre y estar asociada a procesos inflamatorios, infecciosos, tumorales o ser de origen idiopático. Describimos el caso de un adolescente con deterioro neurológico focal dado por hemiplejía derecha en quien se descartaron otras causas más frecuentes de isquemia cerebral, con diagnóstico final de vasculitis primaria del sistema nervioso central asociada a infección por virus de Epstein Barr.


ABSTRACT Primary angiitis of the central nervous system is an uncommon disease that may affect adults and the paediatric population. It can involve both the medium-large and small sized cerebral blood vessels, and can be associated with inflammatory, infectious, tumour processes, or of idiopathic origin. The case is presented of an adolescent with focal neurological impairment due to right hemiplegia, in whom other more frequent causes of cerebral ischaemia were ruled out. The final diagnosis was Epstein Barr virus associated with primary angiitis of the central nervous system.


Subject(s)
Humans , Child , Adolescent , Child Health , Herpesvirus 4, Human , Vasculitis, Central Nervous System , Vasculitis , Blood Vessels , Hemiplegia
17.
Kasmera ; 46(1): 61-69, ene.-jun 2018. tab
Article in Spanish | LILACS-Express | LILACS | ID: biblio-1008094

ABSTRACT

Se realizó un estudio de enteroparásitos en una población indígena, a través del cual se propuso un nuevo procedimiento de diagnóstico para estrongiloidiasis, técnica difásica en tubo (TDT), con el objeto de compararla con la de agar en placa (Arakaki). La metodología consistió en análisis de muestras fecales de 50 individuos mediante examen al fresco, técnica de concentración de Ritchie, técnica de agar en placa y la TDT aquí propuesta. Se obtuvo una prevalencia parasitaria y poliparasitismo elevados, con 94% y 70% respectivamente. Blastocystis spp. (chromista) prevaleció, seguido de Giardia intestinalis, entre los protozoarios, mientras entre los helmintos predominaron los geohelmitos, encabezados por Trichuris trichiura y Strongyloides stercoralis. La sensibilidad y especificidad de la TDT fue 75% y 66,7 %, respectivamente, a las 24 horas de lectura, aislándose la especie 1,5 veces más sobre la técnica tradicional, y de 85,71% y 16,67% a las 48 horas, recuperándose el nemátode 1,6 veces más, mostrando una mayor sensibilidad. No se reportaron casos de estrongiloidiasis a través del examen al fresco, ni por la técnica de Ritchie. Se concluye que la TDT, es más eficaz para diagnóstico de la especie S. stercoralis, tanto a las 24 como a las 48 horas de lectura.


A study of enteroparasites in an indigenous population was carried out, through which a new diagnostic procedure for strongyloidiasis, diphasic technique in tube (DTT), was proposed, in order to compare it with plaque agar (Arakaki). The methodology consisted in the analysis of fecal samples of 50 individuals by means of a fresh test, Ritchie concentration technique, plate agar technique and the DTT proposed here. A high parasitic prevalence and poliparasitism was obtained, with 94% and 70% respectively. Blastocystis spp. (chromist) prevailed, followed by Giardia intestinalis, among the protozoa, while among the helminths the geohelmities predominated, headed by Trichuris trichiura and Strongyloides stercoralis. The sensitivity and specificity of DTT was 75% and 66.7%, respectively, at 24 hours of reading, the species being isolated 1.5 times more on the traditional technique, and 85.71% and 16.67% at 48 hours, recovering the nematode 1.6 times more, showing greater sensitivity. No cases of strongyloidiasis were reported through the fresh examination, nor by the Ritchie technique. It is concluded that DTT, is more effective for diagnosis of the species S. stercoralis, both at 24 and at 48 hours of reading.

18.
Article in English | MEDLINE | ID: mdl-29734709

ABSTRACT

Background: Evidence-based interventions have been developed and tested to promote physical activity, but fewer studies have focused on identifying effective intervention strategies for mid-size rural communities, especially new immigrant destinations. We report here on the design and implementation of Active Ottumwa, a community-wide intervention using a lay health advisor approach to increase physical activity in a micropolitan new destination community in the rural state of Iowa. Methods: The Active Ottumwa study is part of a community-academic partnership in Ottumwa, IA. Evidence-based strategies recommended by the Community Guide for Preventive Services guided study implementation and included behavioral and social, campaign and informational, and environmental and policy approaches. Evaluation methods for this study are multi-faceted and include a cross-sectional community survey, longitudinal cohort assessment, observational data, key informant interviews, and project records. Results: We are currently in our second year of intervention implementation, with 45 lay health advisors (termed physical activity leaders here) trained to carry out behavioral and social intervention approaches, including walking groups, tai chi, and yoga. We have completed a communication and informational campaign utilizing five channels. Our longitudinal cohort has been recruited, with baseline and 12-month data collection completed. Conclusions: This study will assess the effectiveness and impact of a community-wide intervention to support physical activity.


Subject(s)
Exercise , Health Promotion , Preventive Health Services/organization & administration , Cross-Sectional Studies , Health Promotion/methods , Humans , Iowa , Program Evaluation , Rural Population
19.
Cultur Divers Ethnic Minor Psychol ; 24(2): 277-283, 2018 04.
Article in English | MEDLINE | ID: mdl-29154561

ABSTRACT

OBJECTIVES: Exposure to psychosocial stressors is associated with increases in adverse mental health outcomes and inflammatory markers. Limited research has investigated if acculturative stress, related to cultural adaptation in Latinos, one of the fastest growing minority groups in the United States, follows a similar pattern. This study hypothesized that acculturative stress would be associated with increased mental health symptoms as well as increases in salivary inflammatory markers. In addition, it was hypothesized that higher levels of salivary inflammatory markers would mediate the pathways between acculturative stress and mental health symptoms. The ability of salivary inflammatory markers to moderate the relationship between acculturative stress and mental health symptoms was also tested. METHOD: One hundred and fifty-four Latino participants were recruited from a local university. Participants completed measures of acculturative stress, perceived stress, state/trait anxiety, and depressive symptoms. Saliva samples measured C-reactive protein (CRP) and interleukin (IL)-1ß. RESULTS: Acculturative stress was significantly associated with increases in perceived stress, state/trait anxiety and depressive symptoms. Salivary inflammatory markers did not mediate the relationship between acculturative stress and mental health symptoms. Alternatively, CRP, but not IL-1ß, moderated the relationship between acculturative stress and state anxiety, such that when salivary CRP levels were low, there was a positive association between acculturative stress and state anxiety symptoms. DISCUSSION: Results suggests that the interplay between acculturative stress and salivary inflammation might indicate risk for anxiety in vulnerable populations. (PsycINFO Database Record


Subject(s)
Acculturation , Hispanic or Latino/psychology , Inflammation/metabolism , Mental Disorders/psychology , Saliva/metabolism , Stress, Psychological/psychology , Adult , Anxiety Disorders/metabolism , Anxiety Disorders/psychology , Biomarkers/metabolism , Depression/metabolism , Depression/psychology , Female , Hispanic or Latino/statistics & numerical data , Humans , Inflammation/psychology , Male , Mental Disorders/metabolism , Stress, Psychological/metabolism , Students/psychology , Students/statistics & numerical data , United States , Young Adult
20.
Rev. cuba. invest. bioméd ; 34(3): 0-0, ilus
Article in Spanish | LILACS | ID: lil-773358

ABSTRACT

El plasmocitoma óseo solitario y el mieloma múltiple son dos gammapatías monoclonales que pertenecen al mismo grupo de alteraciones neoplásicas de células plasmáticas. En ocasiones el plasmocitoma precede al mieloma. La localización esternal de un plasmocitoma es excepcional. Se reporta el caso de una persona de sexo masculino de 75 años, con dolor moderado en la región dorsal acompañado de disnea de medianos esfuerzos. La tomografía reveló lesiones osteolíticas localizadas en el tercio inferior del esternón, con características radiológicas de un plasmocitoma óseo solitario, además se observan lesiones en la 5ta. costilla izquierda y escápulas. La biopsia de médula ósea evidenció una plasmocitosis medular del 45 % y la inmunoelectroforesis, una concentración de 4210 mg/dl de Inmunoglobulina G. Se hace el diagnóstico de mieloma múltiple y se analizan las alteraciones que lo hicieron evolucionar hasta ese punto con el fin de tener presente la posibilidad de la evolución a mieloma múltiple en aquellos pacientes con plasmocitoma óseo. Se expone el siguiente caso con el objetivo de mejorar la calidad de vida de los pacientes a través del diagnóstico oportuno del plasmocitoma óseo, logrando así evitar la evolución a mieloma múltiple, y resultar en una mayor supervivencia.


Solitary plasmacytoma of bone and multiple myeloma are two monoclonal gammapathies that belong to the same group of neoplastic alterations of plasma cells. The plasmacytoma occasionally precedes myeloma. The sternal location of plasmocytoma is rare. This is the case of a man aged 75 years, with moderate pain in the dorsal region and short of breath when making medium efforts. The axial tomography showed osteolytic lesions in the lower third of sternum with radiological characteristics of a solitary plasmocytoma of bone in addition to lesions in the 5th left rib and scapulas. The bone marrow biopsy revealed 45% medullary plasmocytosis whereas immunoelectrophoresis showed Ig G concentration of 4210 mg/dl. Multiple myeloma was diagnosed and an analysis was made on the alterations leading to this result, with the purpose of bearing in mind the possibility of progression to a multiple myeloma in those patients with plasmocytoma of bone. The following case was presented in order to improve the quality of life of patients through timely diagnosis of plasmocytoma of bone and to avoid progression to multiple myeloma, thus achieving higher survival rates.

SELECTION OF CITATIONS
SEARCH DETAIL
...